Psoriatic arthritis: a systematic review

…, O Kaloudi, M Bertoni, E Cassara - … journal of rheumatic …, 2010 - Wiley Online Library
… -α, induce endothelial cell activation with expression of a variety of adhesion molecules,
including vascular cell adhesion molecule 1, intercellular adhesion molecule 1 (ICAM-1), and E-…

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

F Cantini, L Niccoli, C Nannini, E Cassarà… - Seminars in arthritis and …, 2017 - Elsevier
… Each ITABIO member separately developed and shared by e-mail a single topic, and finally
all members met to examine, discuss, assemble the single elaborates, and to draw up the …

Uveitis in spondyloarthritis: an overview

F Cantini, C Nannini, E Cassarà, O Kaloudi… - The Journal of …, 2015 - jrheum.org
Autoimmune anterior uveitis (AU) accounts for at least half of the cases of noninfectious
uveitis, and similarly to spondyloarthritis (SpA), its occurrence is related to HLA-B27 positivity. …

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

…, C Nannini, M Benucci, D Chindamo, E Cassarà… - 2007 - academic.oup.com
Objectives. To evaluate the long-term efficacy and safety of infliximab in patients with Behçet's
disease (BD) and refractory bilateral posterior uveitis, and to assess the proportion of …

Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

F Cantini, L Niccoli, E Cassarà, O Kaloudi… - Biologics: Targets and …, 2013 - Taylor & Francis
Background The aim of this study was to evaluate the proportion of patients with ankylosing
spondylitis maintaining clinical remission after reduction of their subcutaneous etanercept …

Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs

F Cantini, L Niccoli, C Nannini, E Cassara… - …, 2008 - academic.oup.com
Objective. To evaluate the frequency and duration of clinical remission in patients with PsA.
Methods. All consecutive new outpatients with peripheral PsA requiring second-line drugs …

Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis.

…, E Cassarà, C Alessandri, E Sabatini… - The Journal of …, 2008 - jrheum.org
… In patients with RA treated with methotrexate and infliximab or placebo a reduction in
inflammation and retardation of joint destruction in those who received infliximab was documented …

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

F Cantini, L Niccoli, C Nannini, E Cassara… - Seminars in Arthritis and …, 2016 - Elsevier
… Each member separately developed and shared by e-mail a single topic, and finally all
members met to examine, discuss, assemble the single elaborates, and to draw up the final …

Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study

L Niccoli, C Nannini, E Cassarà… - … journal of rheumatic …, 2012 - Wiley Online Library
Objective The occurrence of iridocyclitis ( IC ) in early psoriatic arthritis ( P s A ) has been
rarely assessed. The primary end‐point of this study was to evaluate the frequency of IC at …

[PDF][PDF] Risk factors for Sjögrenʼs syndrome: a case-control study

R Priori, E Medda, F Conti, EA Cassarà… - Clin Exp …, 2007 - researchgate.net
Objective The aim of this study was to investigate potential risk factors for Sjögrenʼs syndrome
(SS) by means of a multi-centre case-control study, focusing in particular on familial and …